Forsyth Medical Center 
Stroke and Neurovascular Research
| The Forsyth Stroke and Neurovascular Center is actively involved in research studies. |
 |
Our Research Defines Us
Conducting clinical research is important because it makes the latest treatment opportunities and medications available to you. Listed below are a few of the studies Forsyth is involved in are the following:
Rreact Stroke Study
This study is testing a new neuroprotective agent, primarily for use within the first six hours after stroke symptom onset.
Abest 2 Stroke Study
An agent called Abciximab, an anti-platelet compound, is used in this study for acute ischemic stroke.
SB 249417
This study involves the use of a monoclonal IgG antibody for human Factor IX to limit any ongoing thrombosis.
